MIM Corporation And Chronimed (CHMD) Shareholders Approve Merger; BioScrip To Be One Of Largest Specialty Pharmacies In US
10/19/2005 5:12:58 PM
ELMSFORD, N.Y. & MINNEAPOLIS--(BUSINESS WIRE)--March 9, 2005--MIM Corporation (NASDAQ:MIMS) and Chronimed Inc. (NASDAQ:CHMD) today announced that MIM and Chronimed obtained the requisite approvals for the merger of MIM and Chronimed at special shareholder meetings held earlier today.
The holders of Chronimed common stock will receive 1.12 shares of MIM Corporation common stock in the merger. Upon consummation of the merger, MIM and Chronimed become one company and will change its name to BioScrip, Inc. The combined company will trade on Nasdaq National Market under the symbol "BIOS".
comments powered by